Presentation: Humanized Phenotypic Screening Platform for Chronic Pain
Our recent Webinar presented the development of a humanized phenotypic screening platform for pain and CNS drug discovery.
The approach is based on using sensory neurons derived from well-characterised iPSCs (induced Pluripotent Stem Cells) produced by Censo Biotechnologies combined with Cellectricon’s unique screening technologies, IP and know-how.
What we offer:
- A scalable methodology to generate sensory neurons
- Quality control of each batch is monitored at various stages using Immunohistochemistry and qPCR
- Neuronal progenitors are provided to Cellectricon for final ‘in plate’ maturation and functional assay execution
Gain knowledge of compound profiling to advance research in the CNS and pain therapeutic fields and get an understanding of the principles of operation of Cellectricon’s phenotypic screening platform.
Contact us for full presentations or to discuss your requirements.